ALKAMI TECHNOLOGY INC (ALKT)

US01644J1088 - Common Stock

23.86  -0.63 (-2.57%)

After market: 23.86 0 (0%)

Fundamental Rating

4

Overall ALKT gets a fundamental rating of 4 out of 10. We evaluated ALKT against 276 industry peers in the Software industry. While ALKT has a great health rating, there are worries on its profitability. ALKT shows excellent growth, but is valued quite expensive already.



1

1. Profitability

1.1 Basic Checks

ALKT had negative earnings in the past year.
ALKT had a negative operating cash flow in the past year.
In the past 5 years ALKT always reported negative net income.
In the past 5 years ALKT always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -15.74%, ALKT is doing worse than 61.31% of the companies in the same industry.
ALKT's Return On Equity of -19.36% is in line compared to the rest of the industry. ALKT outperforms 50.73% of its industry peers.
Industry RankSector Rank
ROA -15.74%
ROE -19.36%
ROIC N/A
ROA(3y)-12.84%
ROA(5y)-28.6%
ROE(3y)-16.86%
ROE(5y)-75.46%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 54.42%, ALKT is doing worse than 63.87% of the companies in the same industry.
ALKT's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ALKT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y10.81%

8

2. Health

2.1 Basic Checks

ALKT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALKT has more shares outstanding than it did 1 year ago.
There is no outstanding debt for ALKT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

ALKT has an Altman-Z score of 18.08. This indicates that ALKT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 18.08, ALKT belongs to the best of the industry, outperforming 95.26% of the companies in the same industry.
ALKT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 18.08
ROIC/WACCN/A
WACC9.96%

2.3 Liquidity

ALKT has a Current Ratio of 3.77. This indicates that ALKT is financially healthy and has no problem in meeting its short term obligations.
ALKT has a better Current ratio (3.77) than 81.75% of its industry peers.
A Quick Ratio of 3.77 indicates that ALKT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.77, ALKT belongs to the top of the industry, outperforming 81.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.77
Quick Ratio 3.77

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 83.91% over the past year.
The Revenue has grown by 29.65% in the past year. This is a very strong growth!
Measured over the past years, ALKT shows a very strong growth in Revenue. The Revenue has been growing by 40.60% on average per year.
EPS 1Y (TTM)83.91%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q140%
Revenue 1Y (TTM)29.65%
Revenue growth 3Y33.18%
Revenue growth 5Y40.6%
Revenue growth Q2Q28.5%

3.2 Future

Based on estimates for the next years, ALKT will show a very strong growth in Earnings Per Share. The EPS will grow by 197.21% on average per year.
Based on estimates for the next years, ALKT will show a very strong growth in Revenue. The Revenue will grow by 23.65% on average per year.
EPS Next Y605.86%
EPS Next 2Y292.71%
EPS Next 3Y197.21%
EPS Next 5YN/A
Revenue Next Year24.92%
Revenue Next 2Y24.55%
Revenue Next 3Y23.65%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALKT. In the last year negative earnings were reported.
ALKT is valuated quite expensively with a Price/Forward Earnings ratio of 127.48.
ALKT's Price/Forward Earnings ratio is in line with the industry average.
ALKT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.63.
Industry RankSector Rank
PE N/A
Fwd PE 127.48

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALKT's earnings are expected to grow with 197.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y292.71%
EPS Next 3Y197.21%

0

5. Dividend

5.1 Amount

ALKT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ALKAMI TECHNOLOGY INC

NASDAQ:ALKT (4/25/2024, 3:20:01 PM)

After market: 23.86 0 (0%)

23.86

-0.63 (-2.57%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.33B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 127.48
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.74%
ROE -19.36%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 54.42%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.77
Quick Ratio 3.77
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)83.91%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y605.86%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)29.65%
Revenue growth 3Y33.18%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y